TARA PROTARA THERAPEUTICS INC Operational Disruptions 8-K Filing 2023 - Positive Preliminary Data Announcement Protara Therapeutics, Inc. announced positive preliminary data from the ADVANCED-1 Phase 1a Dose Escalation Trial of TARA-002 in NMIBC, supporting its advancement into Phase 2 Clinical Development.Get access to all SEC 8-K filings of the PROTARA THERAPEUTICS INC